5.3 Coma Patterns, Burst Suppression & Prognostication
Key Takeaways
- Coma EEG interpretation separates background continuity, voltage, symmetry, organization, sleep features, and reproducible cerebral reactivity from artifact and drug effects.
- Burst suppression may be pathologic or intentionally produced by anesthetic treatment; report suppression proportion, burst morphology, interburst intervals, medication context, and serial evolution.
- Suppression or burst suppression at least 72 hours after return of spontaneous circulation—or after rewarming when hypothermia was used—and without major confounders is a moderately reliable, not infallible, predictor of poor outcome.
- Bilateral N20 absence at least 48 hours after cardiac arrest is reliable only when peripheral and cervical responses confirm delivery and noise, hypothermia, and technical failure are excluded.
- Neuroprognostication is multimodal and physician-led; technologists produce accurate, reproducible observations and never convert one pattern into a zero-chance outcome claim.
5.3 Coma Patterns, Burst Suppression & Prognostication
Coma is a state of profound unarousability and unresponsiveness resulting from structural, metabolic, or toxic disruption of the Ascending Reticular Activating System (ARAS) in the brainstem, the bilateral thalami, or diffuse bilateral cerebral cortices. In the neuro-intensive care unit, continuous EEG provides an indispensable dynamic window into the depth of coma, residual cortical network integrity, the presence of subclinical seizures, and long-term neurological prognosis.
For the CLTM technologist, distinguishing between benign and malignant coma patterns, titrating therapeutic burst suppression in refractory status epilepticus (RSE), managing Targeted Temperature Management (TTM) recordings, and executing standardized bedside reactivity protocols are core clinical responsibilities.
1. Spectrum of Coma EEG Patterns
Coma produces distinctive electrographic patterns that reflect the underlying pathophysiological mechanism, anatomical lesion site, and degree of cortical network preservation.
+---------------------------------------------------------------------------------------------------------+
| COMA EEG PATTERNS SPECTRUM |
| |
| Coma Pattern Dominant Rhythm / Morphology Etiology & Anatomy Prognostic Value |
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
| | Alpha Coma | Diffuse or anterior-predominant | Severe anoxic brain injury| In anoxia: ||
| | | monotonous 8–12 Hz activity; | (cortical laminar necrosis| Invariably poor; ||
| | | completely UNREACTIVE to stimuli | vs pontine stroke vs toxic| in drug OD: good||
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
| | Spindle Coma | Diffuse 11–14 Hz sleep-spindle- | Closed head trauma (TBI), | Relatively ||
| | | like bursts on slow background; | encephalitis, post-ictal; | FAVORABLE ||
| | | may demonstrate reactivity | intact thalamocortical net| (high survival) ||
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
| | Theta / Delta | Continuous diffuse monomorphic | Metabolic encephalopathy, | Variable; ||
| | Coma | or polymorphic slowing (<8 Hz); | deep white matter injury, | depends on ||
| | | non-reactive or poorly reactive | severe systemic sepsis | reversibility ||
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
| | Beta Coma | Generalized high-amplitude fast | High-dose benzodiazepines,| Excellent if ||
| | | beta activity (>13 Hz) | barbiturates, sedatives | purely toxic ||
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
| | Low-Voltage | Generalized diffuse attenuation | Severe hypoxic-ischemic | Poor if ||
| | Output Coma | (<20 µV across all leads) | injury, hypothermia, brain| unreactive & ||
| | | without discrete bursts | death progression | persistent >72h ||
| +-------------------+ +--------------------------------+ +-------------------------+ +---------------+|
+---------------------------------------------------------------------------------------------------------+
Alpha Coma vs. Normal Alpha Rhythm vs. Locked-In Syndrome
One of the most critical diagnostic distinctions in neurophysiology is separating Alpha Coma from a normal waking alpha rhythm and Locked-In Syndrome.
+---------------------------------------------------------------------------------------------------------+
| ALPHA COMA VS. NORMAL ALPHA VS. LOCKED-IN SYNDROME |
| |
| Clinical Parameter Normal Waking Alpha Alpha Coma (Post-Anoxic) Locked-In Syndrome |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
| | Clinical State | Fully conscious, alert | Deep coma, unarousable | Fully conscious, | |
| | | | | quadriplegic | |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
| | Spatial Field | Posterior dominant (O1/O2)| Diffuse, frontocentral, | Posterior dominant | |
| | | occipital attenuation | or generalized | (normal O1/O2) | |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
| | Reactivity | Prompt eye-opening block | Completely UNREACTIVE to | Intact eye-opening | |
| | | (Berger effect) | intense noxious stimuli | reactivity | |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
| | Frequency Stability | Fluctuates with vigilance | Monotonous, rigid, fixed | Normal fluctuation | |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
| | Motor Signs | Intact voluntary movement | Decerebrate/decorticate | Vertical eye movem. | |
| | | | or flaccid | & blinking preserved | |
| +---------------------+ +-------------------------+ +------------------------+ +--------------------+ |
+---------------------------------------------------------------------------------------------------------+
Spindle Coma
Spindle coma is defined by the electrographic presence of diffuse, synchronous or asynchronous 11–14 Hz sleep-spindle-like activity occurring continuously or intermittently on an encephalopathic slow (theta/delta) background in a comatose patient.
- Pathophysiology: The presence of spindles indicates preservation of the reticular nucleus of the thalamus and functional thalamocortical projection loops, demonstrating that subcortical and cortical grey matter connections remain partially viable.
- Clinical Etiologies: Blunt head trauma (diffuse axonal injury), viral encephalitis, post-ictal stupor, and acute intoxication.
- Prognostic Significance: Patients with spindle coma have a significantly higher probability of survival and neurological recovery compared to patients exhibiting unreactive alpha or theta/delta coma.
2. Burst Suppression: Morphology & Therapeutic Titration
Burst Suppression is an electrographic pattern characterized by alternating periods of high-voltage mixed cerebral activity (bursts, ≥10 µV) and generalized electrical silence (suppression, <10 µV) lasting ≥0.5 seconds.
+---------------------------------------------------------------------------------------------------------+
| BURST SUPPRESSION ARCHITECTURE & RATIO |
| |
| HIGH VOLTAGE BURST (50-150 uV) PERIOD OF SUPPRESSION (<10 uV) |
| /-----------------------------\ /----------------------------------\ |
| / Mixed Spikes, Polyspikes, \ | Isoelectric Electrical Silence | [Next Burst]|
| | Sharp Waves & Delta Waves | | (Target: 10–20 seconds) | /------------|
| ---+---------------------------------+-----------+------------------------------------+--+------------|
| |<--------- Burst Duration ------>|<--------------- Suppression Duration --------->| |
| | | |
| |<---------------------------- Total Recording Epoch ----------------------------->| |
| |
| Burst Suppression Ratio (BSR) = [ Total Suppression Time / Total Epoch Time ] x 100% |
+---------------------------------------------------------------------------------------------------------+
Therapeutic Burst Suppression in Refractory Status Epilepticus (RSE)
When status epilepticus fails to terminate following first-line benzodiazepines and second-line IV anti-seizure medications, it is classified as Refractory Status Epilepticus (RSE). Treatment requires continuous intravenous general anesthetics:
- First-Line Anesthetics: Continuous infusions of Propofol, Midazolam, Ketamine, or Pentobarbital / Thiopental.
- Electrophysiological Target: The standard neuro-intensive care endpoint is titrating continuous anesthetic infusions to achieve electrographic burst suppression with 10 to 20 seconds of inter-burst suppression intervals (corresponding to a Burst Suppression Ratio [BSR] of 80% to 90%) or complete isoelectric suppression.
- Duration & Weaning: Target burst suppression is typically maintained for 24 to 48 hours of continuous seizure freedom before slow, stepwise weaning (over 12–24 hours). The CLTM technologist must continuously monitor cEEG during the weaning phase to detect early recurrence of subclinical seizures or rhythmic discharges on the Ictal-Interictal Continuum.
3. Post-Cardiac-Arrest Neuroprognostication: Pattern, Timing, and Confounders
EEG contributes to prognosis after cardiac arrest, but the recording cannot be interpreted as a stand-alone declaration of neurologic outcome. The technologist’s first responsibility is a technically sound record: document temperature, sedatives and anesthetics, antiseizure medicines, paralytics, metabolic abnormalities, recording continuity, stimulation, and any artifact that limits assessment. Preserve serial changes rather than selecting only the worst epoch.
Current neuroprognostication guidance distinguishes a pattern’s association from the certainty of an individual prediction. A suppressed background or burst-suppression pattern recorded at least 72 hours after return of spontaneous circulation—or at least 72 hours after rewarming when hypothermia was used—without sedation, hypothermia, or another toxic-metabolic confounder is a moderately reliable predictor of poor functional outcome. Earlier suppression can improve, and anesthetic treatment can intentionally create burst suppression. Identical bursts, periodic discharges, status myoclonus, and absent reactivity add clinical concern, but they do not justify an “invariable,” “100%,” or zero-chance conclusion.
The technologist describes observable features using standardized terminology:
- Suppression: nearly all activity below the applicable ACNS voltage threshold.
- Burst suppression: bursts alternating with suppression for the required proportion of the record; report burst morphology, synchrony, interburst interval, and suppression percentage.
- Periodic or rhythmic patterns: record prevalence, frequency, modifiers, evolution, stimulus relationship, and seizures.
- Reactivity: a reproducible change in cerebral EEG frequency or amplitude after a documented stimulus. Muscle, blink, movement, and electrode artifacts are not cerebral reactivity.
- Continuity and recovery: document whether the background becomes more continuous, organized, reactive, or sleep-featured over serial recordings.
SSEP N20 Findings
Median-nerve somatosensory evoked potentials provide a separate physiologic pathway assessment. Bilateral absence of the cortical N20 response at least 48 hours after return of spontaneous circulation can be a reliable poor-outcome predictor when peripheral Erb’s point and cervical responses confirm stimulus delivery and the study is technically interpretable. The team must exclude excessive noise and technical failure; severe hypothermia can abolish responses. Sedation generally has less effect on N20 than it has on EEG, but the complete clinical setting still matters. Report what was recorded and whether technical prerequisites were met—do not translate the finding into “no chance of recovery.”
Multimodal Assessment
A formal prognosis belongs to the treating clinicians and should integrate multiple independent sources: serial neurologic examinations after an appropriate waiting period, pupillary and corneal reflexes, EEG, SSEP, brain imaging, and selected biomarkers. Persistent coma by itself is not equivalent to a poor long-term outcome. Confounders such as renal or hepatic failure, intoxication, sepsis, shock, residual neuromuscular blockade, and delayed drug clearance can extend the needed observation period.
Targeted Temperature Management and Drug Effects
Hypothermia changes cerebral physiology and slows drug metabolism. During cooling and rewarming, annotate temperature transitions, shivering, paralytic administration, sedation changes, and interruptions. EEG remains valuable for seizure detection throughout treatment, but prognostic use of suppression or burst suppression is deferred until the recommended time and after confounders are addressed. If the physician uses anesthetic burst suppression to treat refractory status epilepticus, calculate the requested suppression measure over the specified epoch and report the observation; do not independently change the infusion.
Standardized Reactivity Testing
Use the facility’s ordered sequence and coordinate with nursing so stimuli are safe and reproducible. Common steps include calling the patient’s name, a simple command, gentle tactile stimulation, and a clinician-approved noxious stimulus. Mark the exact start and end of each stimulus. A true response is reproducible and has a plausible cerebral field; EMG, eye movement, cable movement, or bedside handling alone is not EEG reactivity. Stop if stimulation creates harm or conflicts with the care plan.
High-Yield Safety Rules
- Separate seizure-surveillance findings from prognostic interpretation.
- Never call a pattern “invariably fatal” or use an EEG/SSEP result alone to recommend withdrawal of life-sustaining therapy.
- Apply the correct timing: at least 72 hours for prognostic EEG suppression/burst suppression, adjusted to 72 hours after rewarming when hypothermia was used; at least 48 hours for prognostic bilateral N20 absence.
- Verify drug, temperature, metabolic, and technical confounders.
- Escalate seizures and other critical findings under the approved communication policy while preserving a complete, accurately annotated record.
A comatose survivor of cardiac arrest has a suppressed background with burst suppression 80 hours after rewarming. Sedatives have cleared and no major toxic-metabolic confounder is present. How should this pattern be characterized for neuroprognostication?
A comatose patient with refractory status epilepticus is receiving a continuous intravenous infusion of propofol in the neuro-ICU. The neuro-intensivist requests continuous EEG monitoring to titrate the infusion to an electrographic Burst Suppression Ratio (BSR) of 85%. Over a 100-second analysis epoch, what total duration of electrical suppression (<10 µV) must the technologist document to achieve this target?
At least 48 hours after cardiac arrest, median-nerve SSEPs show reproducible Erb’s point and cervical responses but bilaterally absent cortical N20 responses in a technically adequate, low-noise study. What is the most accurate interpretation?
A 45-year-old patient who suffered acute brainstem infarction is evaluated with continuous EEG. The EEG reveals a continuous, unreactive 9.0 Hz alpha-frequency rhythm with a generalized, frontally dominant distribution that shows zero change during intense noxious sternal rub or auditory stimulation. The patient is deeply comatose and flaccid. How is this pattern classified, and how does it differ from Locked-In Syndrome?